Anna Richo
Anna Richo will join biopharmaceutical company UCB as Executive Vice President and General Counsel later on in the year, replacing Bob Trainor who has been in the role for nine years.
Richo comes to UCB from Amgen where she served as Senior Vice President and Chief Compliance Officer since 2008, and prior to this she was at Baxter Healthcare Corporation for 12 years.
Roch Doliveux, UCB’s CEO said: “I am very happy to welcome Anna’s wealth of legal and leadership qualities, which will be a great natural fit with the global teams Bob has led, as well as with UCB’s ongoing journey to becoming the patient-centric global biopharma leader.”